The Modernization of Cosmetics Regulation Act of 2022 sets a heap of new compliance challenges before industry and a range of new litigation risks, attorneys say.
New requirements for product/ingredient listing with the US Food and Drug Administration, serious adverse event reporting, safety substantiation, and good manufacturing practices could introduce new angles for plaintiffs’ attorneys to explore in torts,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?